Duke Clin Rsch Institute

2400 Pratt Street
Durham, North Carolina 27710

We've found

1 trials

at this facility

Study of Bromodomain and Extra-Terminal Protein (BET) Inhibitor RO6870810 as Mono- and Combination Therapy in Advanced Multiple Myeloma

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Durham, NC

Use our guide to learn which trials are right for you!